CNPAX
Price
$73.30
Change
+$0.37 (+0.51%)
Updated
Dec 3 closing price
Net Assets
162.64B
MLMCX
Price
$22.87
Change
+$0.06 (+0.26%)
Updated
Dec 3 closing price
Net Assets
53.72M
Interact to see
Advertisement

CNPAX vs MLMCX

Header iconCNPAX vs MLMCX Comparison
Open Charts CNPAX vs MLMCXBanner chart's image
American Funds New Perspective 529A
Price$73.30
Change+$0.37 (+0.51%)
VolumeN/A
Net Assets162.64B
Morgan Stanley Instl Global Core C
Price$22.87
Change+$0.06 (+0.26%)
VolumeN/A
Net Assets53.72M
CNPAX vs MLMCX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MLMCX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and MLMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. MLMCX (53.7M). CNPAX pays higher dividends than MLMCX: CNPAX (0.46) vs MLMCX (0.00). CNPAX was incepted earlier than MLMCX: CNPAX (24 years) vs MLMCX (10 years). MLMCX (2.80) is less costly to investors than CNPAX (0.77). MLMCX is a more actively managed with annual turnover of: 39.00 vs. CNPAX (24.00). CNPAX has a lower initial minimum investment than MLMCX: CNPAX (250) vs MLMCX (1000). CNPAX annual gain was more profitable for investors over the last year : 11.91 vs. MLMCX (10.64). MLMCX return over 5 years is better than : 49.87 vs. CNPAX (25.34).
CNPAXMLMCXCNPAX / MLMCX
Total Expense Ratio0.772.1037%
Annual Report Gross Expense Ratio0.772.8028%
Fund Existence24 years10 years-
Gain YTD20.10515.915126%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets163B53.7M303,538%
Annual Yield % from dividends0.460.00-
Returns for 1 year11.9110.64112%
Returns for 3 years46.1059.0478%
Returns for 5 years25.3449.8751%
Returns for 10 years101.99N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLFTY3.750.24
+6.84%
RELIEF THERAPEUTICS HLDG AG
AMDUF80.95N/A
N/A
AMUNDI SA
JELCF3.50N/A
N/A
Johnson Electric Holdings Ltd.
PRYNF0.05N/A
N/A
Backstageplay Inc.
SWZNF4626.31N/A
N/A
Schweizerische Nationalbank